Neurofeedback of Amygdala Activity for Post-traumatic Stress Disorder
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Post Traumatic Stress Disorder
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Participants will receive either an experimental feedback intervention or a control feedback intervention. Participants who receive the control feedback intervention will be offered to return to receive the experimental feedback intervention upon completion of the study.Masking: Double (Participant, Outcomes Assessor)Masking Description: Participants will be blind to group assignment (experimental feedback intervention or control feedback intervention). The outcome assessor will be blind to group assignment.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
In pursuit of the overarching goals of this study, the investigators aim to: determine if an experimental feedback intervention increases control over the region of interest (the amygdala) more than a control feedback intervention in which participants receive feedback that is unassociated with thei...
In pursuit of the overarching goals of this study, the investigators aim to: determine if an experimental feedback intervention increases control over the region of interest (the amygdala) more than a control feedback intervention in which participants receive feedback that is unassociated with their PTSD symptoms. determine if an experimental feedback intervention results in clinical improvements in PTSD symptoms relative to a control feedback intervention, and examine whether these improvements correlate with improved control over the amygdala. determine if an experimental feedback intervention results in changes in resting state connectivity to the amygdala, and whether these changes correlate with symptom improvement and an improved ability to regulate the amygdala.
Tracking Information
- NCT #
- NCT03574974
- Collaborators
- VA Connecticut Healthcare System
- Investigators
- Principal Investigator: Ilan Harpaz-Rotem, PhD Yale University School of Medicine, VA Principal Investigator: Michelle Hampson, PhD Yale University
Get Well Soon